LC-MS/MS Determination of Evodiamine in Plasma and Its Pharmacokinetics in Rats after Administration in the Form of Solid Lipid Nanoparticles

Author(s): Yi Feng, Huanli Yin, Xue Zhao, Min Wu*

Journal Name: Current Pharmaceutical Analysis

Volume 16 , Issue 3 , 2020

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: A sensitive, reliable liquid chromatography-tandem mass spectrometry (LCMS/ MS) method has been developed and applied to detect the evodiamine (EVO) in rat plasma after animals were given EVO directly. However there is almost no research on the detection of EVO after animals were given EVO-loaded solid lipid nanoparticles (EVO-SLN).

Objective: In this study, a more sensitive and rapid modified LC-MS/MS method for the quantification of EVO in rat blood was developed and validated to evaluate the role of SLN in vivo.

Methods: Plasma samples were taken from animals orally administered EVO-SLN or free EVO, proteins were extracted using diethyl ether containing the internal standards (IS) arbidol hydrochloride, and the mixture was fractionated by liquid chromatography. Quantitative detection of EVO was based on gradient elution in a mobile phase of acetonitrile-0.2% formic acid in water (70:30, v/v).

Results: The calibration curve was linear (r2>0.999, n=9) over the concentration range from 0.1 to 250 ng/mL. Peaks in triple-quadrupole MS were detected for EVO at m/z 304.2→134.1 and for IS at m/z 479.1→343.0. Mean recovery of EVO was more than 93%. Intra and inter-day precision were within 2.7%. In pharmacokinetics studies, EVO-SLN exhibited much higher bioavailability and absorption than free EVO.

Conclusion: The developed method in this work can provide a sensitive, effective and rapid process for the analysis of EVO in whole blood samples. The pharmacokinetics results suggest that the usefulness of SLN for improving oral bioavailability of poorly soluble drugs.

Keywords: Evodiamine, pharmacokinetics, plasma, solid lipid nanoparticles, LC/MS, validation.

Jiang, J.; Hu, C. Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa. Molecules, 2009, 14(5), 1852-1859.
[] [PMID: 19471205]
Yang, F.; Shi, L.; Liang, T.; Ji, L.; Zhang, G.; Shen, Y.; Zhu, F.; Xu, L. Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinoma. Biochem. Biophys. Res. Commun., 2017, 485(1), 54-61.
[] [PMID: 28189683]
Huang, J.; Chen, Z.H.; Ren, C.M.; Wang, D.X.; Yuan, S.X.; Wu, Q.X.; Chen, Q.Z.; Zeng, Y.H.; Shao, Y.; Li, Y.; Wu, K.; Yu, Y.; Sun, W.J.; He, B.C. Antiproliferation effect of evodiamine in human colon cancer cells is associated with IGF-1/HIF-1α downregulation. Oncol. Rep., 2015, 34(6), 3203-3211.
[] [PMID: 26503233]
Liao, C.H.; Pan, S.L.; Guh, J.H.; Chang, Y.L.; Pai, H.C.; Lin, C.H.; Teng, C.M. Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo. Carcinogenesis, 2005, 26(5), 968-975.
[] [PMID: 15705600]
Wei, L.; Jin, X.; Cao, Z.; Li, W. Evodiamine induces extrinsic and intrinsic apoptosis of ovarian cancer cells via the mitogen-activated protein kinase/phosphatidylinositol-3-kinase/protein kinase B signaling pathways. J. Tradit. Chin. Med., 2016, 36(3), 353-359.
[] [PMID: 27468551]
Bai, X.; Meng, H.; Ma, L.; Guo, A. Inhibitory effects of evodiamine on human osteosarcoma cell proliferation and apoptosis. Oncol. Lett., 2015, 9(2), 801-805.
[] [PMID: 25621054]
Mohan, V.; Agarwal, R.; Singh, R.P. A novel alkaloid, evodiamine causes nuclear localization of cytochrome-c and induces apoptosis independent of p53 in human lung cancer cells. Biochem. Biophys. Res. Commun., 2016, 477(4), 1065-1071.
[] [PMID: 27402273]
Cai, S.; Yang, Q.; Bagby, T.R.; Forrest, M.L. Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. Adv. Drug Deliv. Rev., 2011, 63(10-11), 901-908.
[] [PMID: 21712055]
Hu, J.; Chen, D.; Jiang, R.; Tan, Q.; Zhu, B.; Zhang, J. Improved absorption and in vivo kinetic characteristics of nanoemulsions containing evodiamine-phospholipid nanocomplex. Int. J. Nanomedicine, 2014, 9, 4411-4420.
[PMID: 25258531]
Lin, C.H.; Chen, C.H.; Lin, Z.C.; Fang, J.Y. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers. Yao Wu Shi Pin Fen Xi, 2017, 25(2), 219-234.
[] [PMID: 28911663]
Siram, K.; Raghavan, C.V.; Marslin, G.; Rahman, H.; Divakar, S.; Balakumar, K.; Franklin, G. Characterisation and toxicity evaluation of solid lipid nanoparticles prepared using Quillaja saponin as an emulsifier. Colloids Surf. B Biointerfaces, 2016, 147, 274-280.
Yucel, U.; Elias, R.J.; Coupland, J.N. Solute distribution and stability in emulsion-based delivery systems: an EPR study. J. Colloid Interface Sci., 2012, 377(1), 105-113.
[] [PMID: 22533996]
Ma, X.; Li, J.; Liu, Y. Determination of evodiamine and rutacarpine in zhuyu hewei zhitong capsules by HPLC. Zhongguo Zhongyao Zazhi, 2011, 36(7), 871-873.
[PMID: 21761725]
Yin, W.; Li, M.; Liu, S.; Kang, C.; Wang, Y.; Zhou, Z.; Tong, H. [Determination of evodiamine and rutaecarpine of compound Wuzhuyu cataplasm in plasma by SPE-HPLC: application to its pharmacokinetics]. Zhongguo Zhongyao Zazhi, 2009, 34(22), 2946-2949.
[PMID: 20209967]
Yuan, J.; Wang, Y.; An, R.; Wang, S.; Li, S.J.; Jia, J.Y.; Bligh, S.W.; Wang, X.H.; Ma, Y.M. Simultaneous determination of six alkaloids and one monoterpene in rat plasma by liquid chromatography-tandem mass spectrometry and pharmacokinetic study after oral administration of a Chinese medicine Wuji Pill. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2012, 895-896, 154-161.
[] [PMID: 22503734]
Tang, X.; Huang, Z.; Chen, Y.; Liu, Y.; Liu, Y.; Zhao, J.; Yi, J. Simultaneous determination of six bioactive compounds in Evodiae Fructus by high-performance liquid chromatography with diode array detection. J. Chromatogr. Sci., 2014, 52(2), 149-156.
[] [PMID: 23377650]
Fei, Y.; Rui, Y. Simultaneous determination of berberine and evodiamine in dog plasma by LC-ESI-MS method and its application to pharmacokinetics. J. Chromatogr. Sci., 2011, 49(3), 198-202.
Zhao, Y.; Zhao, Y.; Zhou, X.; Gong, X. Development and validation of an UPLC-ESI-MS/MS method for determination of dehydroevodiamine, limonin, evodiamine, and rutaecarpine in Evodiae Fructus. Pharmacogn. Mag., 2014, 10(39), 374-383.
[] [PMID: 25210328]
Niu, X.T.; Zhang, L.Z.; Feng, Y. Preparation and antitumor activity of solid lipid nanoparticles containing. Zhongchengyao, 2016, 10(10), 2149-2156.
Lin, J.; Yang, T.; Zhang, D. Development of a selective and fast LC-MS/MS for determination of WSJ-537, an xanthine oxidase inhibitor, in rat plasma: Application to a pharmacokinetic study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2016, 1028, 51-55.
[] [PMID: 27322629]
Alves, E.A.; Agonia, A.S.; Cravo, S.M.; Afonso, C.M.; Netto, A.D.P.; de Lourdes Bastos, M.; Carvalho, F.; Dinis-Oliveira, R.J. GC-MS Method for the Analysis of Thirteen Opioids, Cocaine and Cocaethylene in Whole Blood Based on a Modified Quechers Extraction. Curr. Pharm. Anal., 2017, 13(3), 215-223.
Bao, T.; Li, Y.; Weng, X.; Yang, Q.; Zhang, Y.; Dong, Y.; Zhu, X. Studies on pharmacokinetics of evodiamine and rutaecarpine in rats plasma after oral administration extracts of euodiae fructus. Zhongguo Zhongyao Zazhi, 2011, 36(24), 3519-3522.
[PMID: 22368870]
Salminen, H.; Gömmel, C.; Leuenberger, B.H.; Weiss, J. Influence of encapsulated functional lipids on crystal structure and chemical stability in solid lipid nanoparticles: Towards bioactive-based design of delivery systems. Food Chem., 2016, 190, 928-937.
[] [PMID: 26213058]

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 30 March, 2020
Page: [231 - 237]
Pages: 7
DOI: 10.2174/1573412914666180914162528
Price: $65

Article Metrics

PDF: 27
PRC: 1